Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4171671
Max Phase: Preclinical
Molecular Formula: C26H43N3O
Molecular Weight: 413.65
Molecule Type: Small molecule
Associated Items:
ID: ALA4171671
Max Phase: Preclinical
Molecular Formula: C26H43N3O
Molecular Weight: 413.65
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)CCC[C@]2(C)[C@@H]3C(=CC[C@@H]12)[C@@]1(C)CC[C@@]2(C)NC(=N)NC[C@@H]2[C@@]1(C)C[C@H]3O
Standard InChI: InChI=1S/C26H43N3O/c1-22(2)10-7-11-23(3)18(22)9-8-16-20(23)17(30)14-25(5)19-15-28-21(27)29-26(19,6)13-12-24(16,25)4/h8,17-20,30H,7,9-15H2,1-6H3,(H3,27,28,29)/t17-,18+,19-,20-,23+,24-,25-,26-/m1/s1
Standard InChI Key: CFBOZMHKFPJERE-VOEDKNGMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 413.65 | Molecular Weight (Monoisotopic): 413.3406 | AlogP: 4.84 | #Rotatable Bonds: 0 |
Polar Surface Area: 68.14 | Molecular Species: BASE | HBA: 2 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 12.10 | CX LogP: 3.66 | CX LogD: 1.24 |
Aromatic Rings: 0 | Heavy Atoms: 30 | QED Weighted: 0.43 | Np Likeness Score: 2.79 |
1. Cabanillas AH, Tena Pérez V, Maderuelo Corral S, Rosero Valencia DF, Martel Quintana A, Ortega Doménech M, Rumbero Sánchez Á.. (2018) Cybastacines A and B: Antibiotic Sesterterpenes from a Nostoc sp. Cyanobacterium., 81 (2): [PMID:29432010] [10.1021/acs.jnatprod.7b00638] |
Source(1):